Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies

NCT02718755 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Problem with drug supply

Conditions

Hematologic Malignancy

Interventions

DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Erwinase

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]